Brian D. Kelley

Deutsche Telekom (United Kingdom), Andover Eye Associates

Papers

Total Citations

338

H-Index

About

Brian D. Kelley is a prominent bioprocess engineer and biopharmaceutical scientist whose research has significantly advanced the development and optimization of protein purification technologies. His work centers on chromatographic separation science, with a particular focus on streamlining the development of downstream purification processes for therapeutic proteins and biologics. Kelley's most influential contributions lie in pioneering high-throughput screening methodologies for chromatographic separations, transforming what were once time-intensive, resource-heavy development processes into efficient, scalable workflows. His 2008 landmark work on method development and column modeling (212 citations) established foundational frameworks for rapidly surveying large parameter spaces under compressed timelines — a critical challenge in biopharmaceutical manufacturing. Complementing this, his high-throughput investigation of ion-exchange chromatography (126 citations) provided the field with practical tools for resin selection and optimization of key process parameters such as pH and counterion concentration. Together, these contributions have had a measurable impact on how the biopharmaceutical industry approaches purification process development, reducing costs and accelerating timelines for bringing therapeutic proteins to market. His work remains essential reading for scientists and engineers working at the intersection of protein biochemistry and industrial bioprocessing.